Table 2.
Outcome of PuraStat treatment | |
---|---|
Primary use of PuraStat | N = 79 |
Procedure success, n (%) | 74 (94%, 95% CI 88–99) |
Application of additional techniques after Purastat* | 32/74 (43%, 95% CI 32–54) |
Secondary use of PuraStat | N = 32 |
Procedure success, n (%) | 24 (75%, 95% CI 59–91) |
Outcome | |
Overall procedure success, n (%) | 98/111 (88%, 95% CI 82–94) |
Overall therapeutic success after 3 days, n (%) | 96/111 (87%, 95% CI 80–93) |
Overall therapeutic success after 7 days, n (%) | 90/111 (81%, 95% CI 72–88) |
Rebleeding, n (%) | 18/111 (16%, 95% CI 10–24) |
Within 7 days after the procedure | 13 |
After 7 days | 5 |
With bridging to surgery | 5/111 |
95%CI 95% confidence interval
*Additional techniques applied to stabilise haemostasis according to guidelines and/or if deemed necessary by the physician